DI MINNO, GIOVANNI
 Distribuzione geografica
Continente #
AS - Asia 12.714
NA - Nord America 9.974
EU - Europa 7.256
SA - Sud America 1.620
AF - Africa 308
OC - Oceania 19
Continente sconosciuto - Info sul continente non disponibili 13
Totale 31.904
Nazione #
US - Stati Uniti d'America 9.524
SG - Singapore 6.389
RU - Federazione Russa 3.582
CN - Cina 1.990
VN - Vietnam 1.965
BR - Brasile 1.323
HK - Hong Kong 1.307
IT - Italia 831
DE - Germania 495
FI - Finlandia 495
FR - Francia 493
IE - Irlanda 271
CA - Canada 254
NL - Olanda 226
UA - Ucraina 211
GB - Regno Unito 187
JP - Giappone 179
SE - Svezia 173
IN - India 157
BD - Bangladesh 124
MX - Messico 122
AR - Argentina 116
IQ - Iraq 99
ZA - Sudafrica 78
PH - Filippine 65
ES - Italia 64
CI - Costa d'Avorio 55
PK - Pakistan 55
KR - Corea 52
PL - Polonia 50
EC - Ecuador 48
ID - Indonesia 46
TH - Thailandia 43
AT - Austria 39
CO - Colombia 36
TW - Taiwan 35
TR - Turchia 34
MA - Marocco 24
SA - Arabia Saudita 22
UZ - Uzbekistan 22
CL - Cile 21
EG - Egitto 20
VE - Venezuela 20
JO - Giordania 18
KE - Kenya 17
PE - Perù 17
PY - Paraguay 17
TN - Tunisia 16
NP - Nepal 15
BG - Bulgaria 14
CH - Svizzera 13
CZ - Repubblica Ceca 13
AE - Emirati Arabi Uniti 12
SN - Senegal 12
RO - Romania 11
BE - Belgio 10
RS - Serbia 10
UY - Uruguay 10
DO - Repubblica Dominicana 9
ET - Etiopia 9
GT - Guatemala 9
JM - Giamaica 9
AO - Angola 8
AU - Australia 8
BO - Bolivia 8
DZ - Algeria 8
EU - Europa 8
AZ - Azerbaigian 7
GR - Grecia 7
IR - Iran 7
KZ - Kazakistan 7
NI - Nicaragua 7
BB - Barbados 6
HU - Ungheria 6
IL - Israele 6
LT - Lituania 6
LU - Lussemburgo 6
NG - Nigeria 6
PT - Portogallo 6
TT - Trinidad e Tobago 6
EE - Estonia 5
GH - Ghana 5
HN - Honduras 5
MN - Mongolia 5
MY - Malesia 5
BF - Burkina Faso 4
CR - Costa Rica 4
CY - Cipro 4
KG - Kirghizistan 4
KW - Kuwait 4
LA - Repubblica Popolare Democratica del Laos 4
LC - Santa Lucia 4
ML - Mali 4
NC - Nuova Caledonia 4
OM - Oman 4
PA - Panama 4
PS - Palestinian Territory 4
AL - Albania 3
AM - Armenia 3
BA - Bosnia-Erzegovina 3
Totale 31.788
Città #
Singapore 2.735
San Jose 1.684
Hong Kong 1.263
Moscow 852
Chandler 612
Ho Chi Minh City 561
Ashburn 546
The Dalles 476
Santa Clara 468
Hanoi 454
Princeton 444
Beijing 426
Boston 393
Lauterbourg 391
Millbury 380
Nanjing 274
Los Angeles 264
Amsterdam 203
Jacksonville 196
Hefei 187
Buffalo 179
Naples 156
Ottawa 155
Tokyo 147
Wilmington 143
Redondo Beach 125
São Paulo 122
Napoli 109
Des Moines 100
Munich 96
New York 96
Haiphong 89
Nanchang 89
Boardman 87
Da Nang 83
Menlo Park 80
Dallas 76
Hebei 67
Seattle 67
Shenyang 63
Falls Church 61
Mexico City 60
Norwalk 60
Orem 57
Turku 55
Nuremberg 54
Houston 51
Tianjin 50
Jiaxing 47
Frankfurt am Main 43
Warsaw 43
Baghdad 41
Rome 41
Brooklyn 38
Chicago 38
Johannesburg 36
Rio de Janeiro 34
Changsha 33
Denver 33
Hải Dương 32
San Francisco 32
Chennai 31
Stockholm 30
Biên Hòa 29
Milan 29
Montreal 29
Atlanta 27
Dublin 27
Kronberg 26
Helsinki 25
Can Tho 24
Curitiba 24
Kerken 24
Toronto 24
Brasília 23
Krefeld 23
Dhaka 22
Lawrence 22
Nocera Inferiore 22
Seoul 22
Woodbridge 22
London 21
Castellón 20
Council Bluffs 20
Phoenix 20
Tashkent 20
Manchester 19
Redwood City 19
Vienna 19
Guayaquil 18
Thái Nguyên 18
Amman 17
Ann Arbor 17
Bangkok 17
Ribeirão Preto 17
Belo Horizonte 16
Kunming 16
Redmond 16
Campinas 15
Falkenstein 15
Totale 16.722
Nome #
Portal vein thrombosis relevance on liver cirrhosis: Italian Venous Thrombotic Events Registry 230
Perspective - The case for zero bleeds and drug bioequivalence in the treatment of congenital hemophilia A in 2021 199
The management of acute venous thromboembolism in clinical practice - study rationale and protocol of the European PREFER in VTE Registry 193
111° Congresso SIMI 191
Platelet count does not predict bleeding in cirrhotic patients: Results from the PRO-LIVER Study 186
New data from the italian national register of congenital coagulopathies, 2016 annual survey 170
Spontaneous Muscle Hematoma in Patients with COVID-19: A Systematic Literature Review with Description of an Additional Case Series 154
Preventing Venous Thromboembolism in Ambulatory Cancer Patients: The ONKOTEV Study 142
Long-lasting intestinal bleeding in an old patient with multiple mucosal vascular abnormalities and Glanzmann's thrombasthenia: 3-year pharmacological management. 138
Anticoagulant Therapy in Oncologic Patients Undergoing Venous Stenting for Superior Vena Cava Syndrome and Other Interventional Procedures. 138
“A fast and accurate method for genotyping the Angiotensin-Converting Enzyme (ACE) I/D polymorphism” 137
Perioperative handling of patients on antiplatelet therapy with need for surgery. 134
Aberrant F8 gene intron 1 inversion with concomitant duplication and deletion in a severe hemophilia A patient from Southern Italy. 132
Right-to-left shunt, atrial septal aneurysm and thrombophilia in patients with cryptogenic stroke or TIA vs. those with venous thrombo-embolism 132
Endothelin abnormalities in patients with pulmonary embolism. 128
Risk factors and recurrent thrombotic episodes in patients with cerebral venous thrombosis 128
Antiphospholipid syndrome, adrenal failure, dilated cardiomyopathy and chronic hepatitis: an unusual manifestation of multiorgan autoimmune injury? 125
Haemophilia A: molecular insights. 125
Diabetes,vascular complications and antiplatelet therapy: open problems 125
Acquired haemophilia a in the elderly: case reports. 125
Acquired Factor v Inhibitor after Coronavirus Disease 2019 (COVID-19) 125
RASopathies and hemostatic abnormalities: key role of platelet dysfunction 124
Antithrombotic drugs, patient characteristics, and gastrointestinal bleeding: Clinical translation and areas of research 124
The risk of gastrointestinal bleeding in patients receiving dabigatran etexilate: a systematic review and meta-analysis of the literature 124
Oxidative stress and plateletactivation in homozygous homocystinuria 123
The infectious burden in atherothrombosis. 123
The challenge of diagnosing pulmonary embolism in children, pregnant women, and elderly patients: a descriptive review of the literature. 123
Mutational spectrum of F8 gene and prothrombotic gene variants in haemophilia A patients from Southern Italy. 122
Prognostic relevance of oxidative stress measurement in chronic lymphocytic leukaemia 122
Emergency management in patients with haemophilia A and inhibitors on prophylaxis with emicizumab: AICE practical guidance in collaboration with SIBioC, SIMEU, SIMEUP, SIPMeL and SISET 122
Venous thromboembolism in covid-19 compared to non-covid-19 cohorts: A systematic review with meta-analysis 120
Acute coronary syndrome and severe haemophilia: an unusual association with challenging treatment. 119
A fast and accurate method for genotyping the angiotensin-converting enzyme I/D polymorphism. 118
Cardiac Manifestations of Antiphospholipid Syndrome: Clinical Presentation, Role of Cardiac Imaging, and Treatment Strategies 118
Benefits of prophylaxis versus on-demand treatment in adolescents and adults with severe haemophilia A: The POTTER study 117
Asymptomatic and symptomatic deep venous thrombosis in hospitalized acutely ill medical patients: risk factors and therapeutic implications 116
Can serum TGF-beta 1 be used to evaluate the response to antiviral therapy of haemophilic patients with HCV-related chronic hepatitis? 116
Hemostatic variables in homozygous familial hypercholesterolemia. Effect of regular plasma cholesterol removal by low density lipoprotein apheresis. 116
IDO1 suppresses inhibitor development in hemophilia A treated with factor VIII 116
Awareness of individual goals, preferences, and priorities of persons with severe congenital haemophilia A for a tailored shared decision-making approach to liver-directed gene therapy. A practical guideline 115
Methylation reactions, the redox balance and atherothrombosis: the search for a link with hydrogen sulfide 115
ANMCO Position Paper: Long-term follow-up of patients with pulmonary thromboembolism 115
Denaturing HPLC procedure for factor IX gene scanning 114
HELLP syndrome and its relation with the antiphospholipid syndrome. 113
Attempting to remedy sub-optimal medication adherence in haemophilia: The rationale for repeated ultrasound visualisations of the patient's joint status 113
[Absence of an association of the D allele of the ACE gene with arterial pressure in mild-moderate essential arterial hypertension]. 112
Absence of apolipoprotein B3500 mutation in type 2a hyperlipoproteinemia patients and in the general population from southern Italy. 111
Predicting early and delayed bleedings in children who undergo adeno-tonsillectomy surgery. Is it really possible? 111
Prevention of venous thromboembolism in medical patients with thrombocytopenia or with platelet dysfunction: a review of the literature. 110
Systematic reviews and meta-analyses for more profitable strategies in peripheral artery disease. 110
Gastrointestinal bleeding in patients receiving oral anticoagulation: Current treatment and pharmacological perspectives 110
Neutrophil extracellular traps as an adhesion substrate for different tumor cells expressing RGD-binding integrins. 109
Diabetes mellitus and cardiovascular prevention: the role and the limitations of currently available antiplatelet drugs. 109
Prevalence of deep vein thrombosis and pulmonary embolism in patients with superficial vein thrombosis: A systematic review and meta-analysis 109
The first ambulatory screening on thromboembolism: a multicentre, cross-sectional, observational study on risk factors for venous thromboembolism. 108
Biomarkers of subclinical atherosclerosis in patients with psoriatic arthritis 108
Natural anticoagulants deficiency and the risk of venous thromboembolism: A meta-analysis of observational studies 107
Paradigm shift for the treatment of hereditary haemophilia: Towards precision medicine 107
Improving assessment and management of pain in hemophilia: an Italian Delphi consensus statement 107
Ensuring medication adherence with direct oral anticoagulant drugs: lessons from adherence with vitamin K antagonists (VKAs). 106
I nuovi anticoagulanti orali: Raccomandazioni, precauzionie prospettive d'uso 106
The "antiphospholipid triangle" in an asymptomatic patient: a case report. 105
Venous thromboembolism: which patients are truly at risk? 105
Low Rate of Intrahospital Deep Venous Thrombosis in Acutely Ill Medical Patients: Results From the AURELIO Study 104
Left ventricular diastolic abnormalities other than valvular heart disease in antiphospholipid syndrome: An echocardiographic study 104
Comparative analysis of the pivotal studies of extended half-life recombinant FVIII products for treatment of haemophilia A 104
Transient global amnesia in a young woman on prolonged treatment with oral contraceptive drugs. 103
The risk of venous thromboembolism in patients with cirrhosis. A systematic review and meta-analysis 103
Aspirin for preventing the recurrence of venous thromboembolism. 102
Thrombosis in Autoimmune Diseases: A Role for Immunosuppressive Treatments? 102
Carotid intima-media thickness in psoriatic arthritis: Differences between tumor necrosis factor-α blockers and traditional disease-modifying antirheumatic drugs 101
Prevalence of apolipoprotein E alleles in healthy subjects and survivors of ischemic stroke: an Italian Case-Control Study 100
Molecular analysis and genotype-phenotype correlation in patients with antithrombin deficiency from Southern Italy. 100
Arthropathy in patients with moderate hemophilia A: A systematic review of the literature 99
Consensus statements on vaccination in patients with haemophilia—Results from the Italian haemophilia and vaccinations (HEVA) project 99
The real effectiveness of ultrasound guidance in subclavian venous access. 98
Improving the use of direct oral anticoagulants in atrial fibrillation 98
Cost of care of haemophilia with inhibitors. 97
Nutrition, Metabolism, Cardiovascular Disease 97
Noninvasive assessment of liver fibrosis in patients with chronic hepatitis C (and congenital bleeding disorders): where do we stand? 97
Uncomplicated type 1 diabetes and preclinical left ventricular myocardial dysfunction: insights from echocardiography and exercise cardiac performance evaluation. 96
Serum concentrations of the tissue polypeptide specific antigen in patients suffering from non-alcoholic steatohepatitis 95
Cardiovascular Risk in Rheumatic Patients: The Link between Inflammation and Atherothrombosis. 94
Association of TERC and OBFC1 haplotypes with mean leukocyte telomere length and risk for coronary heart disease. 93
Risk profiles and one-year outcomes of patients with newly diagnosed atrial fibrillation in India: Insights from the GARFIELD-AF Registry 93
ABNORMALLY HIGH THROMBOXANE BIOSYNTHESIS IN HOMOZYGOUS HOMOCYSTINURIA. EVIDENCE FOR PLATELET INVOLVEMENT AND PROBUCOL-SENSITIVE MECHANISM. 92
Pain assessment and management in Italian Haemophilia Centres 92
Increased binding of fibrinogen to platelets in diabetes: the role of prostaglandins and thromboxane. 91
Hyperhomocysteinemia and other inherited prothrombotic conditions in young adults with a history of ischemic stroke. 91
Management of ischemic heart disease in hemophiliac patients: new challenges from a case report and review of the literature 90
“Structural and functional cardiovascular abnormalities in never-treated hypertensives according to ACE-gene polymorphism” 90
A role for von Willebrand factor in immune tolerance induction in patients with haemophilia A and inhibitors? 89
Diabetes and cardiovascular disease: Thrombotic risk and aspirin-resistance. 89
Therapeutic management and costs of severe haemophilia A patients with inhibitors in Italy 89
Integrin-dependent cell adhesion to neutrophil extracellular traps through engagement of fibronectin in neutrophil-like cells 89
From unfractionated heparin to pentasaccharide: Paradigm of rigorous science growing in the understanding of the in vivo thrombin generation 89
Physical activity improved by adherence to prophylaxis in an Italian population of children, adolescents and adults with severe haemophilia A: The SHAPE Study 89
Insight into the nature of the CRP-coronary event association using Mendelian randomization. 86
Inherited thrombophilia: implications for prevention and treatment of venous thromboembolism. 86
Factor V Leiden, C > T MTHFR polymorphism and genetic susceptibility to preeclampsia. 86
Totale 11.472
Categoria #
all - tutte 112.615
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 112.615


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202182 0 0 0 0 0 0 0 0 0 0 75 7
2021/20221.962 128 8 2 5 11 30 21 76 274 107 188 1.112
2022/20231.787 480 88 28 116 168 154 1 177 286 177 94 18
2023/20241.323 39 195 169 67 35 26 106 96 10 7 383 190
2024/20259.125 603 895 22 92 98 324 852 466 1.296 1.005 2.659 813
2025/202615.227 1.883 1.043 1.399 1.290 2.733 676 1.727 956 2.237 996 287 0
Totale 32.645